A minority of cases ofautism has been assooiated witb several tlifferent organic conilitions, including bioenergetic metabolism deffciency. Iu a BoBulation-baseil stutly, we screened associateil meilical conditions in a group of 120 chiltlren with autism (current age range lly 5mo to 14y 4mo, mean age 12y 1lmo ISD 9.0mo], male:female ratio 2.9:1). Children were diagnosed using Diagnostic and Statistical lVlanual of Mental Disorders critcria, the Autism Diagnostic Interview -Eeviseil, and the Chiklhood Autism Batins $cale; 767o were diagnosed with typieal autism and 24% with atypical autism. Cognitive functional level was assessed with the Grifffths scale and the Weehsler Intelligence Scale for Ghililren anil was in the normal range inL?o/o. Edlepsy was present in 19 patients. Plasma lactate levels were measured in 89 patienb, anil in 14 we found hyperlactacillemia. Five of 11 patients stuilied were classifled with deffnite mitochondrial respiratotT chain disorder, suggesting that tr[is might be one of the most common disorders associated with autism (5 of 69: 7.2%) anil wa,rranting further investigation.
Autism is a childhood encephalopathy characterized by deficiencies in social interaction and communication, and by repetitive and stereotyped behaviors. Its aetiology remains unknown, although several different specific organic conditions have been found to be associated with autism and autistic-like conditions in about "l,l to 37a/" of cases (Gillberg and Coleman 1995) . The hypothesis of a disturbed bioenergetic metabolism undedying autism has been suggested by the detection of high lactate levels in some patients (Coleman and Blass 1985 ,1,:6uIo et al. 1994 , Chugani et al. 1999 , and by nuclear magnetic resonance imaging as well as positron emission tomography scanning which documented abnormalities in brain metabolism (reviewed in Lombard 1.998). Although the mechanism of hypedactacidemia remains unknown, a likely possibility involves mitochondrial oxidative phosphorylation dysfunction in neuronal cells (Lombard 1998) . Very rarely, cases ofmitochondrial respiratory chain (MRC) disorders have been described as being associated with autism, these include: a 5-year-old child with autism and infantile spasms and documented MRC complex IV deficiency (Liszlo et al . 1994 ); a boy with autism with MRC complex IV defect and a mitochondrial DNA (mtDNA) G8353A mutation whose sister had Leigh syndrome and presented the same MRC complexdeficiency and mtDNAmutation (Graf et al. 2OO0) ; two children with autism with 15q invened duplication, mitochondrial hyperproliferation, and respiratory complex III defqct (Filipek et al. 2OA3) ; and five patients with autism and mtDNA mutations or mtDNA deletion (Pons et al. 2004 ). However, routine metabolic screening and mitochondrial functional studies required for the diagnosis of mitochondrial disease are rarely performed for patients with 4utism, and the hypothesis of an aetiological link between autism and mitochondrial dysfunction has therefore not been properly assessed.
With the purpose of determining the prevalence of autism spectrum disorders and the frequencyof associated pathologies in the Portuguese population, we conducted an epidemiological survey of children aged 7 to 9 years attending Portuguese schools. The study was designed to target about 2O% of the children bom in the years 1990 to 1992 who were attending regular schools, and all children attending special education schools, in the school year l999nO0O. In this context, the children diagnosed with autism underwent a broad aetiological investigation. With the purpose of assessing the hypothesis of metabolic dysfunction leading to autism disorder, we included in this protocol determinations of lactate and pyruvate levels in plasma. The results of the screening of a population-basecl sample for metabolic dysfunction, and the ensuing investiga.tion of its origin, are reported here.
Method POPULATION SAMPLE
In 2OOO we conducted an epidemiological surveyfor autism spectrum disorders in a representative sample ofPornrguese children born during 3 years (1990 to 7992).The survey targeted children aged 7 to 9 years, in the school year 1999/ 2000, attending close to 2Oo/" of randomly selected regular primary schools (1887 schools) utd92% of all special education schools (227 schools following a predefined protocol.
The group of 120 patientswith autism spectrum disorder identified in this study was diagnosed using Diagnostic and Statistical Manual of Mental Disorders (DSM-I!) criteria (American Psychiatric Ass<xiation 1994), theAutism Diagnostic Interview-Revised (ADI-\ Lord et al. 1994 ) and the Childhood Autism Rating Scale (CARS) observational scale (Shopler et d. 1988) . Of the children,T6% (91 of 120) were considered to have typical autism (ADI-R, CARS, and DSM-IV positive) and 24% (29 of l2O) were diagnosed with atypical autism (discordance between ADI-R, CARS, and DSM-I{ with at least one positive). The age of the 120 patients at testing ranged from 10y 6mo to 13y 5mo (mean 12, SD 9.6mo). The male:female ratio was 2.9:1. Cognitive functional level was evaluated using the Griffths Mental Scale II (Griffiths 1984) to determine developmental quotient (DQ), and the Wechsler Intelligence Scale for Children translated into Portuguese and adapted by permission (Marques 1970) to determine IQ. Cognitive functional level was in the normal range in l7V" of the patients G)QIQ> 70), 29o/a had mild to moderate learning disability* (DQ[Q between 35 and 69), and 54% had severe to profound learning disabiliry (DQ/IQ<34). Epilepsy was present in 19 of 720 patients (16%).
Attheoutsetof the study, 15o/"of the parients (18of 120) had a previously identilied associated medical clisorder: chr<> mosomal abnormalities in eight patients; brain infections in four (fwo prenatal); malformative syndr<rmes in four, and septo-optic dysplasia and hypoxic-ischaemic encephalopathy in one patient each. 'l'hese patients did not un<lergo any further aetiological investigation.
I.ABORATORY EVALUATION
Forthe 1O2 childrenwith autismwith no previous indication of associated meclical condition, we conducted abroad laboratory investigation, which included routine testing procedures for fragile X mutations (FR XA and FR XE), chromosomal abnormalities (karyotype study), neurocutaneous syndromes (computer-assisted tomography or nuclear magnetic reso nance neuroimaglng), endocrine (thyrcid function screening), and metabolic disorders (amino acid and organic acid disorders, oligosaccharicles and mucopolysaccharides, purine and pyrimidine disorders, creatine metabolism abnormalities, and congenitaI glycosylation diseases). I'he full predefinecl investigation protocol could only be applied to 56 patients; for the remaining patients, only some of the tests were or had previously been performed. Plasma lactate levels were determined in a total of 69 children; the remaining patients (or their principal caregivers) declinecl to partic! pate in the aetiological investigation.
Lactate and pynrvate in plasma were measured enz.ymntically (Vassault et al. 7991) . Normal plasma lactate values in a paediatric population, collected under the same conditions, have been determined previously (Diogo et al. 1999 ): the mean plasma lactate level determined in a sample of healthy control school-aged children (n=24) was l.l5mmol/L (SD 0.48). For improved specificity, we defined hyperlactacidemia as values of 2.5mmolll or more.
Muscle respiratory chain complex activities in isolated deltoid muscle mitochondria were measured by double-wavelength specrophotometry. Muscle mtDNA, including point *US usage: mental retardation.
L86 Deueloptnental Medlclne & Cbild Neurologlt 2OO5,47: 185-189 mutations G83 63A, A3243G, T 327 lC, T325 6C, T83 5 6C, and large deletions, were assessed by polymerase chain reaction -restriction-fragment-length polymorphism, allele-specific polymerase chain reaction for point mutations, and long polymerase chain reaction for deletions (Rustin etal. 1994) . A histological study was performed by optical microscopy with the usual staining and trichrome Gomori, histoenzymology techniques, namely, nicotinamide adenine dinucleotide dehydrogenase-tetrazolium reductase (NADH:TR), succinate dehydrogenase (SDFD, cytochrome oxidase (COX), and adenosine triphosphatase (ATPase).
MITOCHONDRIAL DISQRDER CLASSIFICATION
The clinicallaboratory classification of these patients was performed in accordance with the revision by Bernier et al. (2002) of current diagnostic criteria in adults for application to paediatric age. In our patients, Iearning disability and hyperlactacidemiawere considered minor criteria (clinical and labofatory respectively). Enzymatic complex activities (expressed as a proportion of citrate synthase acrMty) less than 20% and between 2O and 3O% of the normal mean in muscle were considered major and minor criteria respectively.
MRC disorcler was considered 'definite' if two major or one major plus two minor criteria wefe present, 'probable' if one major plus one minor or at least three minor criteria were present, and 'possible' if one major or two minor criteria (one ofwhich must be laboratory) were present.
'Ihe Ethical Committee at t}re Hospital Pediftrico de Coimbra approved the collection ofdata andbiological specimens liom patients for research purposes. All participants or their legal representatives gave informed consent.
Results
Plasma lactate levels were elevated in 14 of 69 patients (2o.3o/o).In these 14 patients lactate levels were equal to or above 2.5mmol/1. in.at least one cletermination, and ranged from 2.5 to 6.86mmoVl (mean 3.5, SD 1.3). 1'he plasma lactate:pyruvate ratio was obtained in 11 of the 14 patients with hyperlactacidemia; the lactate:pyruvate ratio ranged from 22 to 54.7mmol/L(mean 33.4, SD 10.5) and was elevated (more than 24mmol4) in nine of the 11 testecl patients. Leukocyte pyruvate dehydrogenase deficiency was tested in two patients with hyperlactacidemia, but the lactate:pyruvate ratio w.ds 24 or [ess, and was negative. Plasma and urine amino acids and urine organic acids, determined in all patients, were normal. In the group of patients who undertook the full aetiological investigation protocol (which included the 14 hyperlactacidemic patients), all other tests were negative. Deltoid muscle biopsies were performed in 11 of the L4 childrenwith hyperlactacidemia. Table I summarizes the clinical, biochemical, and genetic findings and the diagnosis classification in patients who underwent muscle biopsy and mitochondrial functional tests. Deficiency of one or more respiratory chain complexes, most frequently of complexes I, I{ and Y was confirmed in six patients. No mtDNA abnormality was found in this group. Muscle histological studies were normal, except for sarcoplasm lipid droplets in three patients with definite MRC disorder.
According to the defined criteria, all 74 patients fulfilled one minorclinical criterion (earning disabiliry) and one minor Iaboratory criterion (hyperlactacidemia) for respiratory ch ain disorder. Five patients showed enzymatic complex activity less than 2O% of the normal mean (major laboratory criterion), one patient had enzymatic complex activity between 20 and30% (minor laboratory criterion), and five otherpatients had enzymatic complex activity above 3O% of normal mean (in the normal range).
In conclusion, five of these 11 patients were classified as having definite MRC disorder, one as probable, and five as possible (lhble I). Clinical data for the five chilfuen with definite MRC disorder are summarized in Thble II. All patients presented with severe typical autism, autistic disorder type, with learning disability ranging from moderate to severe. They had a noffnal neurological examination, without evidence of loss of motor skills. Seizures or otherepisodic phenomenawere not present in this group.
Familyhistorywas irrelevant in three ofthese five children ADI-R,Autism Diagnostic Interview-Revised; CARS, ChildhoodAutism RatingScale (<3O, noautism;3O-36.5, mild to moderate autism; > 37-60, severe autism); DSM-I{ Diagnostic and SEtistical Manual ofMental Disorders; GDQ, global developmental quotient.
Discussion
In the grcup ofpatientswith autism identifiedin this epidemiological study, we found elevated plasma lactatein14of 69,or 20.3o/", of tested patients. It is well known that plasma lactate can be elevated in many conditions besides congenital energy metabolism deficiency, and can even be increased by struggle during venipuncture (Duke 1999) . However, we excluded some common causes for hyrerlactacidemia such as drug use (ralproic acid or zidavodine) or pyruvate dehydrogenase deficiency. In addition, our values are compared with normal plasma lactate values determined in a Portuguese paediaffic population, which were collected under the same conditions (Diogo et al. 1999 ). Diagnosis of MRC disorder was considered definite in five of the 11 patients with hyperlactacidemia who underwent muscle mitochondrial stucties (45.5/o). The finding of mitochondrial dysfu nction in five of 69, or 7.2%, of tested patients with autism from a population-based survey indicates that this disorder is one of the most common medical conditions associated with autism, Clinical phenotype or family histories of the group of five children with the diagnosis of definite MRC disorder was not different from other cases of autism, either associated with other medical conditions or idiopathic. This observ'ation emphasizrs the importance of a full laboratory investigation for the diagnosis of medical conditions associated with autism.
The clifferent final classification for MRC disorder in the twin patients 2 and 3 (one possible and one definite) was somewhat unexpected, given that no mtDNAmutations were found. However, only a panel of the most common mntations and deletions in mtDNA has been tested and, therefore, a mutation elsewhere in the mitochondrial genome cannot be ruled out. lcvels of hetencplasmy can vary within a twin pair (Bendall et al. 7995) , ancl the thresholcl for pathogenicity varies between tissues, although apatient's diagnosis is based on the [unctionnl stu<ly of apparently clinically una-ft'ected tissue, the muscle, and not directly on the affected brain tissue. "I'he discrepancy in classification ofthe twins might, therefore, reflect heterogeneous distribution of mutant mtDNA between the twins and within each individual's tissues, which is consistent with the observed dilferences in biochemical markers. In contrast, even though the patients share the totality of their nuclear genes, mutations in some nuclear genes might have unpredictably heterogeneous consequences in the functioning of mitochondria in different tissues, therefore leading to phenotypic variability even between monozygotic twins. Finally, given the complexity of mitochondrial functions and the limitations of analysis metiods, classification of mitochondrial clisorder is diflicult (Belnier et ^1. 2OO2) and using more or less restrictive criteria woulcl change the classification.
The mechanism by which a mitochondrial dysfunction might lead to autistic behavior is not known, but the direct involvement of an oxidative defect in the disturbance of early brain development is a plausible hypothesis (Lombard 1998). Mitochondrial dysfunction has been associatecl with other behavioral abnormalities besides autism, such as majordepression, which is known to be a frequent psychiatric condition in relatives of children with autism (Bolton et al. 1998 , Gardner et al. 2003 . Several lines ofevidence also suggest an involvement of mitochonclrial dysfu nction in schizophrenia, including documented alterations in brain energy metabolism, in the oxidative phosphorylation system, and in the L88 Deue lopmental tuIed.icine €z Cbi ld Neurologt 2OO5, 47 ; 185-189 expression of genes involved in mitochondrial function (reviewed in Ben-Shachar 2002) .
In our sfudy we have not found any evidence of mtDNA alterations, raising the possibility that nuclear genes are involved in the observed functional abnormalities of mitochondria, at least in some patients. Some isolated cases of MRC disorders due to abnormalities in the mitochondrial genome have been reported (Liszlo et ^1. 1994 , Grafet al. 2000 , and at least one study found a common MRC deficiency in two unrelated children with autism with a similar abnormality in chromosome 15q (Filipek et al. 2003) . A recent report shows that variability in the SLC 2 5A 1 2 gene, encoding the mitochondrial aspartate/glutamate carrier, is associated with autism (Ramoz et aL 2OA4) . A large number of mitochondrial proteins are encoded in the nucleus, and nucleargenes encodingmitochondrial enzymes have been implicated in other neuropsychiatric diseases. For instance, in schizophrenia a defective PRODII2 gene, which encodes proline dehydrogenase, a mitochondrial enzyme involved in the transfer of redox potential across the mitochondrial membrane, increases susceptibility to childhoodonset schiz<rphrenia (Chakravarti 2OO2) . Therefore, it is plausible that deleterious variants of nuclear genes encoding mitochondrial-related proteins, lea<ling to mitochondrial dysfunction, callse autism in some cases, and that this dual genetic basis, involving both the nuclear and mitochondrial genomes, contributes to the heterogeneity observecl in autism. The iclentification of nuclear genes involved in mitochondrial dysfunction associated with autism is likely to bring about major advances in the understanding of the molecular basis of ar,rtism spectrum disorders.
Except for one report by Filiano et ^1.
(2OO2) -who stuclied mitochondrial respilatory en4rme actMty levels, mtDNA and mitochondrial structural abnormalities in l2 children w'ith autisnr -systematic evaluation of mitochondrial function has not usually been performed in patients with alrtism. fb our knowledge, the study presented here is the fust population-based study in which a comprehensive assessment <lf mitochondrial function was perf<rrmed in a relatively large group of patients with autism. Our results indicate that a defect in oxidative phosphorylation might be one of the most common medical conditions associated with autism.
Further investigation is warranted for a futl assessment of the clinical significance of the present findingri, and for an understandingof the pathological pathways bywhich mitochondrial dysfunction can lead to the specific behavioral alterations found in autism. Tuberous sclerosis complex is a genetically determined, variably expressed, multisystem disorder that may affect any human organ with well-circumscribed benign, non-invasive lesions. This book provides a review of the historical background and current criteria for diagnosis, aod detailed descriptions of the clinical manifestations of this protean disease are given. Significant advances in the fields of neuropathology, molecular genetics, and neurobiology are progressing at a fast rate. This books seeks to encapsulate in a single text, knowledge about modem research, ideas and practice on tuhrous sclerosis.
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